220 related articles for article (PubMed ID: 36200632)
1. Association of Direct-to-Consumer Advertising of Prescription Drugs With Consumer Health-Related Intentions and Beliefs Among Individuals at Risk of Cardiovascular Disease.
Eisenberg MD; Singh Y; Sood N
JAMA Health Forum; 2022 Aug; 3(8):e222570. PubMed ID: 36200632
[TBL] [Abstract][Full Text] [Related]
2. Effects of conflicting prescription drug information from direct-to-consumer advertising and drug injury advertising on patients' beliefs and medication adherence.
Im H; Huh J
Res Social Adm Pharm; 2022 Jul; 18(7):3119-3130. PubMed ID: 34454872
[TBL] [Abstract][Full Text] [Related]
3. Critical Test of the Beneficial Consequences of Lifting the Ban on Direct-to-Consumer Advertising for Prescription Drugs in Italy: Experimental Exposure and Questionnaire Study.
Schulz PJ; Crosignani F; Petrocchi S
J Med Internet Res; 2023 Jul; 25():e40616. PubMed ID: 37459159
[TBL] [Abstract][Full Text] [Related]
4. Is exposure to pharmaceutical direct-to-consumer advertising for heart disease and diabetes associated with physical activity and dietary behavior?
Niederdeppe J; Avery RJ; Liu J; Mann C; Sood N; Eisenberg MD
Soc Sci Med; 2023 Aug; 330():116062. PubMed ID: 37418992
[TBL] [Abstract][Full Text] [Related]
5. Direct-to-consumer prescription medication advertisements on social media: The role of social factors.
Fogel J; Shraybman-Buynova J
Health Mark Q; 2023; 40(2):190-205. PubMed ID: 34866544
[TBL] [Abstract][Full Text] [Related]
6. Attention to price disclosures in direct-to-consumer prescription drug advertising and the impact on drug perceptions.
Ball JG; Hollin IL
Res Social Adm Pharm; 2022 Aug; 18(8):3402-3413. PubMed ID: 34819265
[TBL] [Abstract][Full Text] [Related]
7. Messages in prescription drug advertising for four chronic diseases, 2003-2016: A content analysis.
Avery RJ; Niederdeppe J; Eisenberg MD; Sood N; Welch B; Kim JJ
Prev Med; 2022 May; 158():107015. PubMed ID: 35248679
[TBL] [Abstract][Full Text] [Related]
8. A survey of perceptions and attitudes about direct-to-consumer advertising of prescription drugs among college students in South Korea.
Yang YM; Lee JJ; Jeong E; Kim SY; Han MA; Choi EJ
PLoS One; 2018; 13(7):e0201108. PubMed ID: 30040833
[TBL] [Abstract][Full Text] [Related]
9. Living in the "land of no"? Consumer perceptions of healthy lifestyle portrayals in direct-to-consumer advertisements of prescription drugs.
Frosch DL; May SG; Tietbohl C; Pagán JA
Soc Sci Med; 2011 Oct; 73(7):995-1002. PubMed ID: 21843911
[TBL] [Abstract][Full Text] [Related]
10. Direct-to-consumer advertising (DTCA) for prescription drugs: consumers' attitudes and preferences concerning its regulation in South Korea.
Suh HS; Lee D; Kim SY; Chee DH; Kang HY
Health Policy; 2011 Aug; 101(3):260-8. PubMed ID: 21705104
[TBL] [Abstract][Full Text] [Related]
11. Direct-to-Consumer Advertising of Prescription Drugs and the Patient-Prescriber Encounter: A Systematic Review.
DeFrank JT; Berkman ND; Kahwati L; Cullen K; Aikin KJ; Sullivan HW
Health Commun; 2020 May; 35(6):739-746. PubMed ID: 30973021
[TBL] [Abstract][Full Text] [Related]
12. How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA.
Mintzes B; Barer ML; Kravitz RL; Bassett K; Lexchin J; Kazanjian A; Evans RG; Pan R; Marion SA
CMAJ; 2003 Sep; 169(5):405-12. PubMed ID: 12952801
[TBL] [Abstract][Full Text] [Related]
13. Optimistic Bias and Consumer Prescription Drug Decisions: Influences of Direct to Consumer Advertising and Perceived Susceptibility.
Ju I; Park T; Ohs J
Health Commun; 2022 Nov; 37(13):1694-1703. PubMed ID: 33899598
[TBL] [Abstract][Full Text] [Related]
14. Effects of risk disclosure prominence in direct-to-consumer advertising (DTCA) of prescription drugs: An integrative cognitive process model.
Ju I; Park JS
Health Mark Q; 2018; 35(1):32-46. PubMed ID: 29608136
[TBL] [Abstract][Full Text] [Related]
15. Relationship Between Exposure to Direct-To-Consumer Prescription Drug Advertising (DTCA) and Patients' Belief Accessibility and Medication Adherence.
Im H; Huh J
Health Commun; 2019 Aug; 34(9):975-983. PubMed ID: 29521524
[TBL] [Abstract][Full Text] [Related]
16. Consumer's Regulatory Knowledge of Prescription Drug Advertising and Health Risk Awareness: The Moderating Role of Risk Information Prominence.
Ju I; Ohs JE; Park JS
Health Commun; 2020 May; 35(6):696-706. PubMed ID: 30835557
[TBL] [Abstract][Full Text] [Related]
17. Direct-to-consumer prescription medication advertisements and obtaining prescriptions with or without a doctor's prescription.
Fogel J; Zhuk A
Health Mark Q; 2019; 36(3):220-235. PubMed ID: 31267822
[TBL] [Abstract][Full Text] [Related]
18. Optimistic bias, advertising skepticism, and consumer intentions for seeking information about the health risks of prescription medicine.
Park JS; Ahn HA; Haley EJ
Health Mark Q; 2017; 34(2):81-96. PubMed ID: 28590885
[TBL] [Abstract][Full Text] [Related]
19. Perceptions of Direct-to-Consumer Advertising and the Older Adult Population.
Bailey TA; Fenney M
Consult Pharm; 2016 Apr; 31(4):215-20. PubMed ID: 27056358
[TBL] [Abstract][Full Text] [Related]
20. Trends in direct-to-consumer advertising of prescription contraceptives.
Wu MH; Bartz D; Avorn J; Seeger JD
Contraception; 2016 May; 93(5):398-405. PubMed ID: 26808088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
